Photo of Julie Johnson
D United States House · District 32 · Texas

Rep. Julie Johnson

Compare
Total votes
669
all sessions
Attendance
96%
25 missed
Near the chamber average
With party
96%
of cast votes
Near the chamber average
Bipartisan score
2%
crosses aisle rarely
Near the chamber average
Sponsored
485
bills & resolutions
Higher than 81% of chamber peers
Committees
9
assignments
485 bills and resolutions

Sponsored bills

Total
485
Primary
27
Co-sponsor
458
This page
485
matching current filters
Co-sponsor HR 1262
Passed · Indiana House · Co-sponsor
Mikaela Naylon Give Kids a Chance Act

Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.  Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research.  The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)

Passed Dec 2, 2025 1 co-sponsor
Co-sponsor HR 6318
In committee · Indiana House · Co-sponsor
No GOUGE Act

Maddy summaryHR 6318, the No GOUGE Act, prohibits large businesses from excessively raising prices on goods affected by tariffs or planned tariffs (e.g., imports subject to new tariffs) for five years after the tariff takes effect. It specifically targets companies with over $100 million in U.S. revenue, banning price hikes that exceed the actual cost of the tariff plus legitimate operational expenses (excluding executive pay or stock buybacks). The Federal Trade Commission (FTC) enforces this by presuming violations if large firms (over $1 billion revenue) raise prices beyond pre-tariff averages during "tariff shock" periods, though companies can rebut this by proving costs were genuinely tied to the tariff. The law aims to prevent price gouging by ensuring tariff costs - not profit motives - drive price changes for consumers.

In committee Nov 28, 2025 1 co-sponsor
Primary HR 6302
In committee · Indiana House · Lead sponsor
Whistleblowers Aiding National Security Act of 2025

Maddy summaryHR 6302, the Whistleblowers Aiding National Security Act of 2025, creates a program rewarding individuals who report defense export rule violations to the State Department. It establishes a secure online portal for submitting original information (including anonymously), with whistleblowers eligible for awards of 10-30% of civil penalties collected from violators. The bill also prohibits employer retaliation against whistleblowers who report violations, requiring reinstatement or double back pay if fired, and creates a special fund to pay rewards using fines collected under the program. This directly affects individuals reporting defense export violations and employers who might retaliate against them.

In committee Nov 25, 2025 0 co-sponsors
Co-sponsor HR 6312
In committee · Indiana House · Co-sponsor
Tri-Share Child Care Pilot Act of 2025

Maddy summaryThe Tri-Share Child Care Pilot Act of 2025 would establish a 3-year federal pilot program to test shared-cost child care assistance across three parties. It would require states to create programs where eligible parents (with children meeting income limits and age requirements), participating employers, and state lead agencies each pay one-third of qualifying child care costs. The program would be funded with $250 million annually, with states applying for grants to administer the initiative and verify eligibility through employer-parent agreements. The pilot aims to improve child care affordability and access for working families while requiring states to evaluate its impact on employment and child care availability.

In committee Nov 25, 2025 1 co-sponsor
Co-sponsor HR 6199
In committee · Indiana House · Co-sponsor
Medical Nutrition Therapy Act of 2025

Maddy summaryThis bill would expand Medicare Part B coverage to include medical nutrition therapy for beneficiaries with a wider range of chronic conditions beyond current limits (diabetes and kidney disease). It specifically adds conditions like obesity, hypertension, eating disorders, cancer, gastrointestinal diseases, and HIV to the list of covered illnesses, allowing coverage for prevention, management, or treatment. The bill also allows more healthcare providers - including dietitians, nurse practitioners, and clinical psychologists - to deliver these services. This change would directly affect millions of Medicare beneficiaries managing these conditions who previously lacked coverage for medically necessary nutrition therapy.

In committee Nov 20, 2025 1 co-sponsor
Co-sponsor HR 6166
In committee · Indiana House · Co-sponsor
Lowering Drug Costs for American Families Act

Maddy summaryThis bill expands Medicare's drug price negotiation program to cover 50 drugs (up from 20) and requires health insurers to apply negotiated prices to cost-sharing for beneficiaries. It establishes annual out-of-pocket cost-sharing limits for prescription drugs under group health plans and insurance coverage, with specific limits of $2,000 for self-only coverage in 2027 that will increase annually. The bill also sets specific cost-sharing limits for insulin products, requiring coverage with no deductible and cost-sharing of no more than $35 per 30-day supply or 25% of the negotiated price. These provisions affect Medicare beneficiaries, people with group health plans, and health insurers across the country. The bill applies to plan years beginning on or after January 1, 2027.

In committee Nov 20, 2025 1 co-sponsor
Co-sponsor HR 6212
In committee · Indiana House · Co-sponsor
Good Samaritan Menstrual Products Act

Maddy summaryHR 6212, the Good Samaritan Menstrual Products Act, protects donors and nonprofits from liability when providing menstrual products in good faith. It shields people, manufacturers, distributors, and nonprofits from civil or criminal liability for the condition of "apparently usable" donated products (those meeting all safety standards but not necessarily marketable). The law applies to products like tampons, cups, and liners distributed to individuals in need through nonprofits. Liability protection does not apply if gross negligence or intentional misconduct causes injury or death.

In committee Nov 20, 2025 1 co-sponsor
Co-sponsor HR 6181
In committee · Indiana House · Co-sponsor
John Lewis Every Child Deserves a Family Act

Maddy summaryHR 6181, the John Lewis Every Child Deserves a Family Act, prohibits child welfare agencies receiving federal funds from discriminating against children, youth, or prospective foster/adoptive parents based on religion, sex (including sexual orientation and gender identity), or marital status. It directly affects LGBTQ youth in foster care - overrepresented at 30% of the system - who face higher risks of trauma, group home placements, and suicide attempts compared to non-LGBTQ peers. Key provisions require agencies to collect data on sexual orientation and gender identity, establish a National Resource Center for LGBTQ youth support, provide cultural competency training, and eliminate discriminatory practices. The law aims to improve safety, permanency, and placement stability by expanding access to family-based care and ensuring equitable services for all children in the system.

In committee Nov 20, 2025 1 co-sponsor
Co-sponsor HR 6172
In committee · Indiana House · Co-sponsor
Ending Forced Arbitration of Race Discrimination Act of 2025

Maddy summaryHR 6172, the Ending Forced Arbitration of Race Discrimination Act of 2025, prevents companies from requiring employees or consumers to use private arbitration to resolve race discrimination claims. It makes any pre-dispute arbitration agreement unenforceable for disputes involving alleged race, color, or national origin discrimination under federal, tribal, state, or local law. The bill ensures courts - not arbitrators - determine if this law applies to a case, giving people the choice to pursue claims in court instead of forced arbitration. It directly affects individuals alleging race discrimination who would otherwise be barred from court by such agreements. The law applies to claims arising on or after its enactment date.

In committee Nov 20, 2025 1 co-sponsor
Co-sponsor HR 6126
In committee · Indiana House · Co-sponsor
United States Foreign Service Commemorative Coin Act

Maddy summaryHR 6126 authorizes the minting of commemorative coins to mark the 100th anniversary of the U.S. Foreign Service (established in 1924). It specifies three coin types: up to 50,000 $5 gold coins (90% gold), 400,000 $1 silver coins (90% silver), and 750,000 half-dollar coins, all to be sold during 2029. A surcharge of $35 per gold coin, $10 per silver coin, and $5 per half-dollar is added to the sale price, with all surcharge funds directed to the Association for Diplomatic Studies and Training to support its diplomatic history preservation work. The coins must include standard inscriptions (e.g., "Liberty," "United States of America") and will be legal tender, but the bill does not create new policy or affect government operations.

In committee Nov 19, 2025 1 co-sponsor
Showing 161 to 170 of 485 bills
Previous 1 … 16 17 18 … 49 Next